Highly emissive planarized B,N-diarylated benzonaphthoazaborine compounds for narrowband blue fluorescence.

Highly fluorescent blue emitters with high color purity are of great significance for optical applications. Herein, a series of planarized B,N-diarylated benzonaphthoazaborine compounds, namely, BzNp (1), BuBzNp (2), Bu2BzNp (3), Bu2BzMeNp (4), and Bu2BzBuNp (5), where electron-donating t Bu and Me groups are differently introduced into the B-Ph, N-Ph, or benzoazaborine rings, are prepared and characterized. All compounds exhibit low-energy absorptions (λ abs = 462-467 nm) and emissions (λ PL = 472-478 nm) remarkably red-shifted compared with those found for the pristine dibenzoazaborine compound (404 and 415 nm, respectively). Although the expansion of π-conjugation in the azaborine ring by replacing one phenyl ring with a naphthyl ring is mainly responsible for the redshifts, the emission is also fine-tuned by attached alkyl groups, which have a greater impact on the B-centered LUMO level at the azaborine ring than at the B-Ph ring. The bandgap control and emission tuning are further supported by electrochemical and theoretical studies. Notably, blue to sky-blue fluorescence of all compounds exhibits unitary photoluminescence quantum yields, narrow full width at half maximum values (∼20 nm), and small Stokes shifts (∼11 nm), indicating strong emissions with high color purity.

Effect of surfactant on the in vitro dissolution and the oral bioavailability of a weakly basic drug from an amorphous solid dispersion.

This study aimed to investigate the effect of a surfactant on the liquid-liquid phase separation, dissolution, diffusion, and the oral bioavailability of a weakly basic drug (l-tetrahydropalmatine; l-THP) from an amorphous solid dispersion (ASD). The carrier used in the ASD was optimized by the application of casting film, solvent shift, and pH shift methods. The interaction between the optimized carrier (HPMCP) and l-THP was then evaluated by Fourier transform-infrared spectroscopy and powder X-ray diffraction. The impact of the surfactant on ASD prepared by the spray-drying method was evaluated by both in vitro and in vivo studies. The results of in vitro studies, including liquid-liquid phase separation, drug diffusion, and pH-shift dissolution, indicated that the addition of a surfactant at a certain concentration below critical micelle concentration to ASD caused the precipitation of and a reduction in the membrane diffusion of l-THP in pH 6.8. This observation was confirmed in an in vivo study in which the drug concentration of l-THP in rabbit plasma was determined by the LC-MS/MS analysis method. Then the absolute and relative bioavailability of l-THP was calculated from the obtained pharmacokinetic parameters. Specifically, the addition of 1.5% surfactant (Poloxamer 188) to the binary ASD decreased the relative bioavailability of l-THP by approximately 2.4 times compared with the original binary ASD. Besides, the study proved that l-THP had low absolute bioavailability (around 1.24%), and the application of binary ASD was meaningful in enhancing the oral bioavailability of l-THP by around 334.77% compared to the raw material. The study is expected to provide a better understanding of how different dosage forms influence the bioavailability of l-THP, thereby allowing the selection of the optimal approach for this weakly basic drug.